{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:37:22Z","timestamp":1787312242077,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijo.ijo_262_16","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T02:19:28Z","timestamp":1494987568000},"page":"295","source":"Crossref","is-referenced-by-count":26,"title":["Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor"],"prefix":"10.4103","volume":"65","author":[{"given":"Rupak","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Saurabh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnindyaKishore","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SwakshyarSaumya","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.206321-1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/09273940490518883","article-title":"Subretinal neovascular membranes complicating uveitis: Frequency, treatments, and visual outcome","author":"Perentes","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.206321-2","first-page":"897","article-title":"Inflammatory choroidal neovascularisations","author":"Winterhalter","year":"2012","journal-title":"Klin Monbl Augenheilkd"},{"key":"key-10.4103\/0301-4738.206321-3","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/IAE.0b013e31815e9834","article-title":"Intravitreal bevacizumab (Avastin) injection as primary treatment of inflammatory choroidal neovascularization","author":"Ad\u00e1n","year":"2007","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.206321-4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/IAE.0b013e3181c96a00","article-title":"Bevacizumab for choroidal neovascularization related to inflammatory diseases","author":"Kramer","year":"2010","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.206321-5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/IAE.0b013e3182003ca8","article-title":"Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization","author":"Rouvas","year":"2011","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.206321-6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/IAE.0b013e3181ed8cec","article-title":"Intravitreal bevacizumab for inflammatory choroidal revascularization: Results from the Pan-American collaborative retina study group at 24 months","author":"Arevalo","year":"2011","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.206321-7","doi-asserted-by":"crossref","unstructured":"Mansour AM, Arevalo JF, Ziemssen F, Mehio-Sibai A, Mackensen F, Adan A, et al. Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol 2009;148:310-6.e2.","DOI":"10.1016\/j.ajo.2009.03.023"},{"key":"key-10.4103\/0301-4738.206321-8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/0974-9233.58422","article-title":"Inflammatory choroidal neovascularization","author":"Neri","year":"2009","journal-title":"Middle East Afr J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0974-9233","issn-type":"print"},{"key":"key-10.4103\/0301-4738.206321-9","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0161-6420(96)30515-0","article-title":"Etiology of choroidal neovascularization in young patients","author":"Cohen","year":"1996","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.206321-10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0161-6420(95)30968-2","article-title":"The natural history of idiopathic subfoveal choroidal neovascularization","author":"Ho","year":"1995","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.206321-11","doi-asserted-by":"crossref","unstructured":"Chan WM, Lai TY, Lau TT, Lee VY, Liu DT, Lam DS. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: One-year results of a prospective series. Retina 2008;28:71-80.","DOI":"10.1097\/IAE.0b013e31815e9339"},{"key":"key-10.4103\/0301-4738.206321-12","first-page":"1347","article-title":"Argon laser photocoagulation for ocular histoplasmosis: Results of a randomized clinical trial","author":"Macular","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.206321-13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/eye.1998.62","article-title":"The use of corticosteroids for choroidal neovascularisation in young patients","author":"Flaxel","year":"1998","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/0301-4738.206321-14","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/archopht.116.11.1456","article-title":"Immunosuppressive treatment of choroidal revascularization associated with endogenous posterior uveitis","author":"Dees","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.206321-15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/bjo.2005.089458","article-title":"Two-year results of surgical removal of choroidal neovascular membranes related to non-age-related macular degeneration","author":"Essex","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.206321-16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/09273940590951124","article-title":"Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like)","author":"Postelmans","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.206321-17","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.206321-18","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.206321-19","doi-asserted-by":"crossref","unstructured":"Baxter SL, Pistilli M, Pujari SS, Liesegang TL, Suhler EB, Thorne JE, et al. Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol 2013;156:468-77.e2.","DOI":"10.1016\/j.ajo.2013.04.040"},{"key":"key-10.4103\/0301-4738.206321-20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","article-title":"International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease","author":"Bloch-Michel","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.206321-21","unstructured":"Smith RE, Nozik RA. Uveitis: A Clinical Approach to Diagnosis and Management. 2nd ed. Baltimore: Williams and Wilkins; 1989. p. 23-6."},{"key":"key-10.4103\/0301-4738.206321-22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/0301-4738.31936","article-title":"Global variation and pattern changes in epidemiology of uveitis","author":"Rathinam","year":"2007","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.206321-23","first-page":"121","article-title":"Pattern of uveitis in a referral eye clinic in North India","author":"Singh","year":"2004","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.206321-24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4103\/0301-4738.170973","article-title":"The changing patterns of uveitis in a tertiary institute of Northeast India","author":"Das","year":"2015","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.206321-25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/0301-4738.73728","article-title":"Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis","author":"Rishi","year":"2011","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.206321-26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/0301-4738.82005","article-title":"Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis","author":"Shah","year":"2011","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.206321-27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/0301-4738.77039","article-title":"Flare up of choroiditis and choroidal neovasculazation associated with punctate inner choroidopathy during early pregnancy","author":"Rao","year":"2011","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.206321-28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ophtha.2010.04.016","article-title":"Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: A phase I clinical trial","author":"Heier","year":"2011","journal-title":"Ophthalmology"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:48:31Z","timestamp":1786632511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_262_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"alternative-id":["206321"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_262_16","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}